A recently published study showed that unstable housing was the only demographical factor linked to severe acute respiratory syndrome reinfection despite the antibody's presence from the first infection.
An antibody developed during the time of SARS helped researchers from MassBiologics find another antibody that is effective in fighting coronavirus. The unique IgA antibody may be used to develop an effective vaccine.
A new study conducted by researchers from Rockefeller University reveals that every person who's ever had an infection of the coronavirus develops neutralizing antibodies. However, they also found that these antibodies might not be enough to prevent a second infection. Click the link above to learn more.
Within the next two months, Standford aims to produce enough for public use. They claim this will help many to move forward and plan to possibly go back to work after the knowledge of obtaining immunity. Click the link above to learn more.